Until durability data are available, chronic maintenance therapy analogous to treatment paradigms for other chronic liver conditions is likely required to sustain hepatic benefits
These changes synergize with the GLP-1s effects for instance, as the medication curbs appetite, coaches help patients to leverage that effect by establishing a more balanced meal pattern, so they can nourish their bodies adequately while still maintaining a calorie deficit
Renal impairment GLP-1 RAs are generally safe in patients with CKD and have demonstrated nephroprotective effects in the FLOW trial, where semaglutide significantly reduced the composite renal endpoint (hospitalization for acute kidney injury, sustained 50% decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, or renal death) in patients with type 2 diabetes and CKD [15]
Pendulum GLP-1 Probiotic Pro as a companion to pharmaceutical GLP-1 medications An increasingly common use case that deserves its own discussion
The greatest neuroprotective effects were seen by the use of DA4-JC and DA-CH5 which improve motor function, protect dopaminergic neurons, reduce inflammation, and rescue glial cell line-derived neurotrophic factor levels [114]
GLP-1RA therapy inhibits glucagon secretion, at least transiently delays gastric emptying, and reduces appetite and food intake [60,61]
.png)
